Focal segmental glomerulosclerosis and chronic kidney disease in pediatric patients

Jeremy Kiffel1, Yael Rahimzada, Howard Trachtman

  • 1Division of Nephrology, Department of Pediatrics, Cohen Children's Medical Center, New Hyde Park, 11040, USA.

Insights

Focal segmental glomerulosclerosis (FSGS) is a growing cause of kidney failure with no effective treatments for non-responders. Research highlights genetic factors and the urgent need for clinical trials for better FSGS therapies.

Area of Science:

  • Nephrology
  • Glomerular Diseases
  • Kidney Health

Background:

  • Focal segmental glomerulosclerosis (FSGS) is a leading cause of acquired glomerular disease and end-stage kidney disease, with increasing global incidence.
  • Current treatment options are limited, particularly for patients unresponsive to corticosteroids, and recurrence after kidney transplantation affects 20-25% of recipients.
  • FSGS can be primary or secondary to conditions like obesity, infections, and vesicoureteral reflux, with recent research implicating genetic mutations in podocyte proteins.

Purpose of the Study:

  • To underscore the critical need for developing novel and effective therapeutic strategies for focal segmental glomerulosclerosis (FSGS).
  • To emphasize the importance of investigating genetic factors contributing to FSGS.
  • To advocate for the initiation of randomized clinical trials to address FSGS in both native and transplanted kidneys.

Main Methods:

  • Review of current literature on FSGS etiology and treatment.
  • Analysis of factors contributing to primary and secondary FSGS.
  • Identification of knowledge gaps in FSGS management and research.

Main Results:

  • Focal segmental glomerulosclerosis (FSGS) is a significant and increasing cause of kidney failure worldwide.
  • Genetic mutations in podocyte proteins are increasingly recognized as a cause of FSGS.
  • There is a lack of proven therapies for FSGS patients who do not respond to standard treatments.

Conclusions:

  • There is an urgent requirement for randomized clinical trials to establish safe and effective therapies for focal segmental glomerulosclerosis (FSGS).
  • Further research into the genetic underpinnings of FSGS is crucial for therapeutic development.
  • Improved treatments are needed for FSGS affecting native and transplanted kidneys.

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Nephrons01:10

Nephrons

The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma happens...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Renal Corpuscle01:20

Renal Corpuscle

The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...